A guide to events on our campuses.

Assembly Series

A tradition of convening thought leaders since 1953

McKelvey School of Engineering

BME Seminar: Junghae Suh, PhD

Thursday, January 27 | 10:00 AM - 11:00 AM

Virtual Event

Presenting on "Gene therapy for neuroscience"

Junghae Suh, PhD, vice president, head of Gene Therapy Accelerator Unit, Biogen, Cambridge, MA, will speak at 10:00 CST on Thursday, January 27, 2022. This seminar is virtual and registration is required. Register for this seminar.

Abstract: Decades of biological research have unveiled the genetic cause of many debilitating diseases that affect the central nervous system (CNS). We are at a point where we aim to translate that knowledge into potential one-time treatment options and curative therapies.  Gene therapy as a therapeutic modality is continuing to evolve and we have seen important advances propelling the field forward. However, additional focused innovation is needed to overcome the complex challenges in gene therapy for neurological diseases. Challenges regarding the delivery platform, cargo, vector production, and vector performance characterization as well as potential solutions to these challenges will be discussed.

Hosts: Professors Chao Zhou and Michael Vahey, Washington University in St. Louis

This seminar is virtual and registration is required. Register for this seminar.

Event Type



McKelvey School of Engineering


Science & Technology, Medicine & Health

Biomedical Engineering


Event Contact

Mimi Hilburg | mhilburg@wustl.edu

Speaker Information

In 2019, Dr. Junghae Suh joined Biogen as head of the Gene Therapy Accelerator Unit (GTxAU) to develop transformative gene therapies for the treatment of neurological diseases.

Dr. Suh received her SB in Chemical Engineering from MIT in 1999 and a PhD in Biomedical Engineering from Johns Hopkins School of Medicine in 2004. She then completed a two-year postdoctoral fellowship in the Laboratory of Genetics at the Salk Institute for Biological Studies. She is a tenured member of the faculty in the department of Bioengineering at Rice University.

She was awarded the NSF CAREER Award and the Outstanding New Investigator Award from the American Society for Gene and Cell Therapy for her innovative work on reprogramming viruses as therapeutic platforms.

Most recently, she was inducted into the American Institute for Medical and Biological Engineering (AIMBE). Her academic work has been funded by the National Institutes of Health, National Science Foundation, and the American Heart Association.

Google Calendar iCal Outlook